Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
38.63
-0.27 (-0.69%)
Dec 20, 2024, 4:00 PM EST - Market closed

Xenon Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
2.95B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20229.43M-9.00M-48.83%
Dec 31, 202118.44M-13.73M-42.68%
Dec 31, 202032.17M25.34M371.02%
Dec 31, 20196.83M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 10.59B
QuidelOrtho 2.82B
Envista Holdings 2.50B
Warby Parker 742.53M
Amicus Therapeutics 493.67M
Veracyte 425.33M
Merus 35.93M
Janux Therapeutics 13.05M
Revenue Rankings